
Opinion|Videos|August 15, 2023
CheckMate 9ER: Quality of Life Data and Treatment Implications in Advanced RCC
Author(s)Rana R. McKay, MD
Expert perspective on CheckMate 9ER quality of life data and treatment implications for patients with advanced RCC.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Poll Results Reveal Readers’ Top Abstracts at SABCS 2025
2
Aromatase Inhibitors Favored as Adjuvant ET in HR+/HER2+ Early Breast Cancer
3
ASCENT-07: Sacituzumab PFS Not Significant vs Chemo in HR+/HER2- BC
4
Off-the-Shelf In Vivo BCMA CAR T KLN-1010 Yields Deep R/R Myeloma Responses
5









































